Neogen Chemicals Limited NEOGEN NSEINFRA
Company Overview
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, suzuki coupling, hydrogenation, and biocatalysis. It serves pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, specialty polymers, vapor absorption chillers, emerging battery material applications, and other industries. The company also exports its products to 33 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.
Recent Developments
- Mar 2026 Revenue of ₹848.34 Cr (+12.2% YoY); net profit ₹28.75 Cr.
- Trailing 12 Months Year-on-year growth — revenue +12.2%, earnings -17.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 8.7%, profit CAGR -16.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 8.70% |
| 1 Year: | 12.22% |
Compounded Profit Growth
| 5 Years: | -16.83% |
| 1 Year: | -17.46% |
Stock Price Performance
| 1 Year: | +47.78% |
| 6 Months: | +60.74% |
| 3 Months: | +10.32% |
| 1 Month: | +5.29% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)48.67 · Neutral
P/E of 196.14 is above the sector median of 27.43 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 196.1.
- Earnings shrank at -16.8% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NEOGEN Neogen Chemicals Limited NSEINFRA | 2,137.90 | 196.14 | ₹5,640.14 Cr | 0.05% | 5.95% | 3.52% | 8.70% | -16.83% |
| 2 | ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA | 11,408.00 | 41.12 | ₹3.36 L Cr | 1.99% | 11.84% | 10.66% | 11.92% | 17.26% |
| 3 | JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA | 1,325.00 | 14.52 | ₹3.24 L Cr | 0.54% | 18.75% | 22.30% | 3.61% | 75.28% |
| 4 | HINDZINC Hindustan Zinc Limited NSEINFRA | 601.00 | 18.36 | ₹2.54 L Cr | 3.56% | 61.97% | 61.13% | 5.61% | 9.58% |
| 5 | ASIANPAINT Asian Paints Limited NIFTY50NSEINFRA | 2,527.30 | 56.03 | ₹2.42 L Cr | 1.00% | 24.41% | 20.24% | 1.10% | 1.75% |
| 6 | TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA | 188.79 | 21.83 | ₹2.36 L Cr | 2.11% | 11.32% | 10.56% | -1.59% | 7.21% |
| 7 | HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA | 1,011.00 | 16.79 | ₹2.27 L Cr | 0.49% | 9.42% | 9.80% | 7.10% | 9.87% |
| 8 | GRASIM Grasim Industries Limited NIFTY50NSEINFRA | 3,322.00 | 59.86 | ₹2.26 L Cr | 0.31% | 3.98% | 4.80% | 14.30% | -10.06% |
| 9 | SOLARINDS Solar Industries India Limited NSEINFRA | 21,445.00 | 115.68 | ₹1.94 L Cr | 0.06% | 29.51% | 26.72% | 12.39% | 30.36% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 204.00 Cr | 165.00 Cr | 162.00 Cr | 164.00 Cr | 200.00 Cr | 180.00 Cr | 193.00 Cr | - | - | 186.73 Cr | 208.66 Cr | 220.02 Cr | 246.56 Cr | 250.29 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | 101.75 Cr | 111.55 Cr | 116.37 Cr | 136.80 Cr | 133.03 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | - | 84.98 Cr | 97.11 Cr | 103.65 Cr | 109.76 Cr | 117.26 Cr |
| Operating Expenses | 171.00 Cr | 137.00 Cr | 136.00 Cr | 144.00 Cr | 164.00 Cr | 149.00 Cr | 159.00 Cr | - | - | 59.25 Cr | 74.46 Cr | 78.58 Cr | 73.45 Cr | 76.49 Cr |
| Operating Income | 29.00 Cr | 23.00 Cr | 20.00 Cr | 14.00 Cr | 30.00 Cr | 24.00 Cr | 28.00 Cr | - | - | 25.73 Cr | 22.65 Cr | 25.07 Cr | 36.31 Cr | 40.77 Cr |
| EBITDA | 33.00 Cr | 28.00 Cr | 26.00 Cr | 20.00 Cr | 36.00 Cr | 31.00 Cr | 35.00 Cr | - | - | 32.74 Cr | 31.94 Cr | 34.10 Cr | 44.92 Cr | 52.29 Cr |
| Interest Expense | 9.00 Cr | 11.00 Cr | 11.00 Cr | 11.00 Cr | 10.00 Cr | 10.00 Cr | 13.00 Cr | - | - | 12.67 Cr | 19.48 Cr | 21.51 Cr | 21.47 Cr | 20.81 Cr |
| Pretax Income | 21.00 Cr | 14.00 Cr | 11.00 Cr | 6.00 Cr | 22.00 Cr | 16.00 Cr | 15.00 Cr | - | - | 14.29 Cr | 5.15 Cr | 5.76 Cr | 15.85 Cr | 23.28 Cr |
| Tax Provision | 6.51 Cr | 3.92 Cr | 3.08 Cr | 4.86 Cr | 5.50 Cr | 4.32 Cr | 4.35 Cr | - | - | 4.03 Cr | 1.78 Cr | 2.07 Cr | 4.46 Cr | 6.17 Cr |
| Net Income | 14.00 Cr | 10.00 Cr | 8.00 Cr | 1.00 Cr | 17.00 Cr | 11.00 Cr | 11.00 Cr | - | - | 10.26 Cr | 3.37 Cr | 3.69 Cr | 11.39 Cr | 17.11 Cr |
| Diluted EPS | 5.74 | 3.91 | 3.18 | 0.40 | 6.42 | 4.35 | 4.15 | - | - | 3.89 | 1.28 | 1.40 | 4.32 | 6.29 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 84.00 Cr | 100.00 Cr | 110.00 Cr | 161.00 Cr | 239.00 Cr | 306.00 Cr | 336.00 Cr | - | 660.48 Cr | 670.83 Cr | 755.94 Cr | 848.34 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 406.84 Cr | 404.08 Cr | 444.25 Cr | 492.81 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 253.64 Cr | 266.75 Cr | 311.69 Cr | 355.53 Cr |
| Operating Expenses | 71.00 Cr | 86.00 Cr | 90.00 Cr | 132.00 Cr | 196.00 Cr | 248.00 Cr | 272.00 Cr | - | 158.22 Cr | 179.56 Cr | 202.28 Cr | 245.58 Cr |
| Operating Income | 12.00 Cr | 13.00 Cr | 19.00 Cr | 27.00 Cr | 40.00 Cr | 53.00 Cr | 57.00 Cr | - | 95.42 Cr | 87.19 Cr | 109.41 Cr | 109.95 Cr |
| EBITDA | 13.00 Cr | 14.00 Cr | 20.00 Cr | 29.00 Cr | 43.00 Cr | 58.00 Cr | 64.00 Cr | - | 110.93 Cr | 113.42 Cr | 115.81 Cr | 129.58 Cr |
| Interest Expense | 5.00 Cr | 5.00 Cr | 8.00 Cr | 10.00 Cr | 12.00 Cr | 12.00 Cr | 14.00 Cr | - | 23.70 Cr | 37.78 Cr | 37.86 Cr | 60.98 Cr |
| Pretax Income | 8.00 Cr | 8.00 Cr | 12.00 Cr | 17.00 Cr | 29.00 Cr | 41.00 Cr | 44.00 Cr | - | 71.03 Cr | 52.77 Cr | 50.16 Cr | 41.08 Cr |
| Tax Provision | 2.96 Cr | 3.12 Cr | 3.96 Cr | 6.29 Cr | 8.12 Cr | 12.30 Cr | 12.76 Cr | - | 21.06 Cr | 17.12 Cr | 15.33 Cr | 12.33 Cr |
| Net Income | 5.00 Cr | 5.00 Cr | 8.00 Cr | 11.00 Cr | 21.00 Cr | 29.00 Cr | 31.00 Cr | - | 49.97 Cr | 35.65 Cr | 34.83 Cr | 28.75 Cr |
| Diluted EPS | 11.31 | 2.59 | 3.84 | 5.49 | 10.43 | 12.28 | 13.43 | - | 20.03 | 13.96 | 13.20 | 10.90 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 69.00 Cr | 80.00 Cr | 152.00 Cr | 180.00 Cr | 246.00 Cr | 355.00 Cr | 492.00 Cr | - | 1,053.80 Cr | 1,461.40 Cr | 1,747.31 Cr | 2,901.87 Cr |
| Current Assets | - | - | - | - | - | - | - | - | 655.83 Cr | 783.66 Cr | 999.83 Cr | 1,392.51 Cr |
| Cash & Equivalents | - | - | - | - | - | - | - | - | 18.22 Cr | 12.23 Cr | 4.96 Cr | 4.94 Cr |
| Inventory | - | - | - | - | - | - | - | - | 292.97 Cr | 382.44 Cr | 309.13 Cr | 568.23 Cr |
| Receivables | - | - | - | - | - | - | - | - | 177.38 Cr | 281.69 Cr | 200.22 Cr | 380.36 Cr |
| Total Liabilities | - | - | - | - | - | - | - | - | 571.28 Cr | 701.11 Cr | 957.91 Cr | 2,085.60 Cr |
| Current Liabilities | - | - | - | - | - | - | - | - | 409.74 Cr | 526.97 Cr | 733.40 Cr | 1,187.67 Cr |
| Long Term Debt | - | - | - | - | - | - | - | - | 129.08 Cr | 124.23 Cr | 170.10 Cr | 819.15 Cr |
| Total Debt | 24.00 Cr | 26.00 Cr | 69.00 Cr | 82.00 Cr | 120.00 Cr | 137.00 Cr | 222.00 Cr | - | 369.51 Cr | 408.92 Cr | 596.74 Cr | 1,395.09 Cr |
| Total Equity | 23.00 Cr | 28.00 Cr | 42.00 Cr | 50.00 Cr | 70.00 Cr | 156.00 Cr | 183.00 Cr | - | 482.52 Cr | 760.29 Cr | 789.40 Cr | 816.27 Cr |
| Shares Outstanding | - | - | - | - | - | - | - | - | 2.49 Cr | 2.64 Cr | 2.64 Cr | 2.64 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 9.00 Cr | 9.00 Cr | 0 | 12.00 Cr | -4.00 Cr | -35.00 Cr | 84.00 Cr | - | -30.35 Cr | -29.15 Cr | 195.98 Cr | -231.48 Cr |
| Investing Cash Flow | -2.00 Cr | -4.00 Cr | -33.00 Cr | -13.00 Cr | -20.00 Cr | -29.00 Cr | -135.00 Cr | - | -94.46 Cr | -215.58 Cr | -316.59 Cr | -410.26 Cr |
| Financing Cash Flow | -6.00 Cr | -4.00 Cr | 33.00 Cr | -0 | 24.00 Cr | 63.00 Cr | 51.00 Cr | - | 100.29 Cr | 236.53 Cr | 113.07 Cr | 641.71 Cr |
| Capital Expenditure | -2.00 Cr | -5.00 Cr | -33.00 Cr | -13.00 Cr | -20.00 Cr | -28.00 Cr | -135.00 Cr | - | -103.74 Cr | -302.77 Cr | -317.71 Cr | -555.72 Cr |
| Free Cash Flow | 7.00 Cr | 4.00 Cr | -33.00 Cr | -1.00 Cr | -24.00 Cr | -63.00 Cr | -51.00 Cr | - | -134.09 Cr | -331.92 Cr | -121.73 Cr | -787.20 Cr |
| Net Change in Cash | 1.00 Cr | 0 | 1.00 Cr | -1.00 Cr | 0 | -1.00 Cr | -0 | - | -24.52 Cr | -8.20 Cr | -7.54 Cr | -3.00 L |
Ratios (Annual)
Figures in %.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | 38.4% | 39.8% | 41.2% | 41.9% |
| Operating Margin % | 14.3% | 13.0% | 17.3% | 16.8% | 16.7% | 17.3% | 17.0% | - | 14.4% | 13.0% | 14.5% | 13.0% |
| Net Margin % | 6.0% | 5.0% | 7.3% | 6.8% | 8.8% | 9.5% | 9.2% | - | 7.6% | 5.3% | 4.6% | 3.4% |
| ROE % | 21.7% | 17.9% | 19.0% | 22.0% | 30.0% | 18.6% | 16.9% | - | 10.4% | 4.7% | 4.4% | 3.5% |
| ROCE % | - | - | - | - | - | - | - | - | 14.8% | 9.3% | 10.8% | 6.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NEOGEN
Is Neogen (NEOG) Already Overvalued After A 106% Run? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQaUc3M2lxREpiV2w4azBtWG1qUEY4S3JDSDRxUDBTQnBodm1fLXhVZWo1OER1ZHBfTVYtXzJsM3NXQ1pWQUtpejZvRWFITkZuX01jSE1fX2lJZVN0Q3k3cS1saDlpbDlKWVR0bTI2VXh2OUkwZDc2Nkg5TnlxSWN5SnBEcGZrU3JHdDJtck…
The Manufacturers Life Insurance Company Takes $956,000 Position in Neogen Corporation $NEOG - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxObEtZeHhpSENna1g4aGJ5cjZpQ0RCYVNKVEM1SlkwMHhETy1udWFZQ2xtZWhtN0xWTlQ1Q0ZSQ2k1R1c0ZkQ5Ym52bUh5TzBXVF9FV3B3NkFLZnRWdjJFRlRyendiQ2tfNlZUTkxCWThjcVUyUHg1REU2WHhfZGhkSTA4RHNOLU1aWDZtYn…
Why Did Neogen (NEOG) Lose A Board Member And What Changes Now? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOY1NUcVhxNmlMdHdNSTBhNlpaV2xCTmdnRy1tZ0NRMUd4cVJxV0lHZlcwSWF1c2wtU2tLRzJRLWdFQjhyZ2tQVExuZGg0S0Q3R0pYVThacHVGWGVZZXNkcDNCXzdweFlDY0tNaGYydDZJXzVhN2wybE5PTTBjOHRzejJNVFpUVk9sWUdJd2…
Neogen stock upgraded at Piper Sandler (NEOG:NASDAQ) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE0yYlhvYThvN20wVWhndDhucHdEME5kbVRNTjlrVW1QS016aDRaaWhpa0F2dGNGOEJtbVFvcFhEQkJVRDJWbXlBWU4xb1RYVmEyendJWE9tZURGR2M1UkxsWVQ4SGo3R1JpQ2ZkLUJnMlJUTDAzdWxjNTFoZ09Xdw?oc=5" target="_blan…
Neogen (NEOG) Following Sales Pressure And Higher Debt, Is The Rebound Already Priced In - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOeVVkYUowSWRHTGFhbmRjZGtKaWJhMmtqSmJFblhSSE5heWZBeWNncmo4NF83WGZMcmxnTDlKdE0yeDRhb3dvMVNTWmRoWWpSRlJxXzRfYVlrNnJBei1oVHJnTHVLRkpnVXdsV3BOdDFLdWZUcVI2WWNuVEp1MjVYUFNCUndWZ2c1RXMtYm…
Why is Neogen stock climbing today? - Investing.com
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQOE5oLVJvaDZpV1NqX3JJUDNNRllpdjZvS0ZxQlpUaTVLdjdKTWl1UmtsYS1qTi1vV0x2b2xSX2dDMzk5bXVHZWRCUFFhd3F6NFR4cDF2ZGk2SDZmcmlJVFdpdzBfd0JkczA1VHI3VUs2eF9raUllelNYR3NQbkdia3VXaERaSGhqTGY1ME…
NEOGEN — Frequently Asked Questions
What is the current share price of Neogen Chemicals Limited (NEOGEN)?
As of 2026-09-08 04:53 IST, Neogen Chemicals Limited (NEOGEN) trades at ₹2,137.90 on NSE. Its 52-week range is ₹979.33 to ₹2,328.80.
What is the market capitalisation of NEOGEN?
Neogen Chemicals Limited (NEOGEN) has a market capitalisation of ₹5,640.14 Cr on NSE.
What is the P/E ratio of NEOGEN?
NEOGEN trades at a trailing price-to-earnings (P/E) ratio of 196.14. The industry average P/E is 27.43. Its price-to-book (P/B) ratio is 6.56.
Does NEOGEN pay a dividend?
Neogen Chemicals Limited (NEOGEN) currently offers a dividend yield of 0.05%.
What is the return on equity (ROE) of NEOGEN?
NEOGEN has a return on equity (ROE) of 3.52%. Its return on capital employed (ROCE) is 5.95%.
Is NEOGEN a good stock to buy?
This page provides a data-driven analysis of Neogen Chemicals Limited (NEOGEN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.